1- (indolymethyl) 2,3,4,9-tetrahydro-1H-beta-carbolines prepared from tryptamine or from its derivatives
Gaignault, J.C.; Fréchet, D.; Nédelec, L.
Annales Pharmaceutiques Francaises 36(11-12): 561-568
1978
ISSN/ISBN: 0003-4509 PMID: 754635 Document Number: 126168
Document emailed within 1 workday
Related Documents
Beck, O.; Bosin, T.R.; Holmstedt, B.; Lundman, A. 1982: A GC-MS study on the occurrence of two tetrahydro-beta-carbolines implicated in alcoholism Progress in Clinical and Biological Research 90: 29-40Buckholtz, N.S. 1982: Interaction of tetrahydro-beta-carbolines with brain serotonin metabolism Progress in Clinical and Biological Research 90: 183-190
Bosin, T.R. 1985: A simple, sensitive procedure for the determination of tetrahydro-beta-carbolines and their precursors Progress in Clinical and Biological Research 183: 179-188
Misztal, S.; Boksa, J.; Chojnacka-Wójcik, E.; Tatarczyńska, E.; Lewandowska, A. 1987: Synthesis and pharmacological properties of some 2-substituted 1-(3-pyridyl)-1,2,3,4-tetrahydro-beta-carbolines Polish Journal of Pharmacology and Pharmacy 39(1): 97-103
Mokrosz, J.L.; Dukat, M.; Misztal, S.; Chojnacka-Wójcik, E.; Tatarczyńska, E. 1990: Structure-activity relationship studies of CNS agents. Part 1: the Free-Wilson analysis of acute toxicity and sedative effect of some 1,2,3,4-tetrahydro-beta-carbolines Die Pharmazie 45(10): 765-767
Nawrocka, W.; Rutkowska, M.; Szelag, A.; Barczyńska, J.; Kedzierska-Goździk, L.; Błaszczyk, F.; Dziwiszek, W. 1996: Synthesis and pharmacological properties of new derivatives of 4-methyl-5-oxalo-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin-2-one and beta-oxo-5-(4-methyl-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin-2 -one)propionic acid Acta Poloniae Pharmaceutica 53(6): 425-430
Grote, C.; Clement, H.W.; Wesemann, W.; Bringmann, G.; Feineis, D.; Riederer, P.; Sontag, K.H. 1995: Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives Journal of Neural Transmission. Supplementum 46: 275-281
Boksa, J.; Charakchieva-Minol, S.; Duszyńska, B.; Bugno, R.; Kłodzińska, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E.; Bojarski, A.J. 2003: Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety Polish Journal of Pharmacology 55(6): 1013-1019
Sasaki, T.; Abiko, N.; Uchida, H.; Tanaka, M.; Nitta, K.; Yoshioka, Y.; Nomura, H. 1983: Antitumor activity of tetrahydro-2-furanyl- and tetrahydro-2-pyranyl-glucans obtained by chemical modification of (1 leads to 3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 and its lower molecular weight glucans Cancer Treatment Reports 67(3): 275-280
Aftab, K.; Aslam, K.; Kousar, S.; Nadeem, M.J.U.H. 2016: Synthesis, characterization and biological evaluation of tryptamine based benzamide derivatives Pakistan Journal of Pharmaceutical Sciences 29(2): 423-428
Nantka-Namirski, P.; Piechaczek, J.; Wrotek, J. 1976: Synthesis of derivatives of 1,2,3,4-tetrahydro-5H-(1) benzopyrano (2,3-b) pyridin-5-one Acta Poloniae Pharmaceutica 33(6): 669-672
Heikkila, R.E.; Cohen, G. 1974: The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives Research Communications in Chemical Pathology and Pharmacology 7(3): 539-547
Blaskó, G.; Blaskó, G.; Szántay, C. 1987: Octahydroindolo[2,3-a]quinolizines and 3,4-dihydro-beta-carbolines as new inhibitors of human platelet aggregation Arzneimittel-Forschung 37(6): 667-669
Wojnar, R.J.; Alpaugh, W.C.; Dzelzkalns, E. 1985: Characterization of the anti-inflammatory activity and reduced potential for dermal atrophy of (11 beta, 16 beta)-9-fluoro-1',2',3', 4'-tetrahydro-11,21-dihydroxypregna-1,4-dieno[16,17-b]naph thalene-3, 20-dione hydrate (1 : 1) (SQ 26,490), a topically active corticoid Arzneimittel-Forschung 35(8): 1264-1268
Peczyńska-Czoch, W.; Mordarski, M.; Kaczmarek, L.; Nantka-Namirski, P. 1987: Microbial transformation of azacarbazoles. I. N-methylation of alpha-, beta-, and gamma-carbolines by Kitasatosporia setae strain Archivum Immunologiae et Therapiae Experimentalis 35(2): 89-95
Herraiz, T. 2000: Analysis of the bioactive alkaloids tetrahydro-beta-carboline and beta-carboline in food Journal of Chromatography A 881(1-2): 483-499
Kari, I.; Peura, P.; Airaksinen, M.M. 1979: Mass fragmentographic determination of tetrahydro-beta-carboline in human blood platelets and plasma Medical Biology 57(6): 412-414
Sontag, K.H.; Heim, C.; Sontag, T.A.; God, R.; Reichmann, H.; Wesemann, W.; Rausch, W.D.; Riederer, P.; Bringmann, G. 1995: Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats Journal of Neural Transmission. Supplementum 46: 283-289
Rausch, W.D.; Abdel-mohsen, M.; Koutsilieri, E.; Chan, W.W.; Bringmann, G. 1995: Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures Journal of Neural Transmission. Supplementum 46: 255-263
Zdorenko, V.A.; Vladzimirskaia, E.V. 1977: Arylidene and heterylidene derivatives of beta,beta'-bis-(thiazolidindion-2,4-yl-3)-diethyl ether Farmatsevtychnyi Zhurnal 1977(6): 28-31